TRUSELTIQ FDA approval date

The FDA approved TRUSELTIQ on 28 May 2021.

FDA approval date
28 May 2021

Drug identity has not yet been verified against registry records

Also recorded as INFIGRATINIB PHOSPHATE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2021-05-28DayTRUSELTIQFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA214622", "applicant_as_listed_by_fda": "HELSINN HLTHCARE", "brand_names": ["TRUSELTIQ"], "active_ingredients": ["INFIGRATINIB PHOSPHATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20210528", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026